Skip to main content
MED logo

MED

Medifast, Inc.

$11.43

0.06%

Trade Ideas Performance

Latest Closed Trade Idea

$11.43

0.06%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

9

Social

62

About

Events of Medifast, Inc. (MED)

Over the past six months, Medifast's stock price declined by 17.81% (September 22, 2025, to September 18, 2026) and by 12.55% over the last year, largely due to the impact of GLP-1 medications on the traditional weight management market. In Q1 2026, revenue decreased by 34.3% to $76.0 million, with a net loss of $2.1 million, and Q2 2026 saw a net loss of $3.10 million on $76.4 million revenue, down 28% from Q2 2025, though Q2 results exceeded analyst expectations. In response, Medifast introduced Trilivy (July 2026) and OPTAVIA ASCEND (January 2025), announced the Medifast Metabolic Health Institute (August 2026), suspended its dividend at the end of 2023, and invested in LifeMD to offer clients access to GLP-1 medications.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)